Loading organizations...
BrightInsight provides a global platform for regulated digital health solutions across biopharma and medtech. Its scalable, cloud-based infrastructure enables rapid, compliant development and deployment of digital health applications, including Software as a Medical Device. The platform delivers essential technical and regulatory frameworks, accelerating innovation for life sciences organizations.
Co-founded by Kal Patel, MD, Ferry Tamtoro, and Ben Lee, who met at Amgen in 2014, BrightInsight emerged from recognizing the challenges in efficiently delivering regulated digital health solutions within life sciences. This insight led Kal Patel to establish the company within Flex in 2017, formally launching in 2018, offering a focused platform for this specialized need.
BrightInsight supports biopharma and medtech organizations improving patient outcomes via digital therapeutics and connected devices. Its mission accelerates health transformation, delivering value to life sciences partners through a secure, compliant platform. The company’s vision is to fundamentally enhance patient care through advanced digital technology.
BrightInsight has raised $178.0M across 4 funding rounds.
BrightInsight has raised $178.0M in total across 4 funding rounds.
BrightInsight has raised $178.0M in total across 4 funding rounds.
BrightInsight's investors include Eclipse, General Catalyst, Insight Partners, Mayo Clinic, Vijay Lathi, Eclipse Ventures, Quiet Capital, New Leaf Venture Partners.
BrightInsight is a regulated digital‑health technology company that offers a managed, medical‑grade cloud platform to build, launch, and scale companion apps, connected devices, algorithms and Software as a Medical Device (SaMD) for biopharma and medtech customers[3][5].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: BrightInsight occupies a strategic position as a medical‑grade, managed cloud platform built specifically to remove technical and regulatory friction for biopharma and medtech digital products; its success will hinge on continued enterprise wins, measurable clinical and commercial impact from deployed solutions, and the company’s ability to expand analytics and global regulatory support as the digital‑health market matures[3][2][5].[3][2][5]
BrightInsight has raised $178.0M across 4 funding rounds. Most recently, it raised $13.0M Other Equity in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 20, 2026 | $13.0M Other Equity | Eclipse, General Catalyst, Insight Partners, Mayo Clinic, Vijay Lathi | |
| Mar 1, 2021 | $100.0M Series C | General Catalyst | Eclipse Ventures, Insight Partners, Quiet Capital, New Leaf Venture Partners |
| Jun 1, 2020 | $40.0M Series B | Insight Partners | Eclipse Ventures, Vijay Lathi |
| Sep 1, 2019 | $25.0M Series A | Eclipse Ventures, Vijay Lathi |